表紙
市場調査レポート

CountryFocus:中国の医療・規制・医療費償還制度の状況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China

発行 GlobalData 商品コード 278789
出版日 ページ情報 英文 258 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
CountryFocus:中国の医療・規制・医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
出版日: 2016年01月19日 ページ情報: 英文 258 Pages
概要

当レポートでは、中国の医療関連市場の動向や、医療費償還制度およびその他の関連規制・制度について分析し、医薬品産業・医療装置産業の全体的構造・動向、医療費償還制度やその周辺の保険市場の動向、医療規制当局の構造や各種規制の概要、日本経済・社会に関するマクロ的指標(医療インフラなど)といった情報をまとめています。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
    • 市場概況
    • 医薬品の輸出入
    • 供給経路
    • 市場の分類
    • 主な疾患分野
    • 主要企業
  • 医療機器市場
    • 市場概況
    • 上位5分野の概況
    • 診断市場
    • 主要企業
  • 市場促進要因と障壁
    • 促進要因
    • 課題

第4章 市場へのアクセス

  • 医療費償還・保険料支払者の状況
    • 医療制度の概要
    • 医療費償還過程
    • 保険業者の概要
    • 医療費支出に対する患者負担の比率
    • 処方薬の価格動向
    • 薬価政策
  • 規制環境
    • 規制機関の概要
    • 新薬の認証過程
    • ジェネリック医薬品の認証過程
    • 医療機器新製品の認証過程
    • 医薬品・医療機器の製造認可過程
    • 医薬品の輸出・輸入の認可
    • 知的所有権
    • 治験関連の規制
    • 医薬品の広告に関する規制
    • 薬局関連の規制
    • ラベリング・包装に関する規制

第5章 国の分析

  • 政治環境
  • 経済環境
  • 経済指標
  • 人口統計
  • 医療インフラ
    • 医療施設
    • 医療関連パラメーター
    • 環境問題
    • 医療従事者
  • 医療費支出
    • 概要
    • 医療費支出の主な要素
    • 公共/民間部門のシェア
  • 業界団体
  • 展示会

第6章 市場機会と課題

  • 市場機会
  • 課題

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0052CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.

The population of China in 2014 was approximately 1.37 billion, having grown at a Compound Annual Growth Rate (CAGR) of 0.5% from 2008. The country's increasingly elderly population and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical industry, which was estimated to be worth $106.5 billion in 2008 and is projected to reach $1,637.3 billion by 2020, at a CAGR of 25.6%. Approximately 95% of China's population has healthcare coverage. Improvements in drug safety and quality; a shorter drug registration timeline; the elimination of price caps by the government; a more transparent system for the approval of drugs and medical instruments; and an IPR regime are driving innovation in the pharmaceutical sector. These changes encourage foreign Multinational Companies (MNC) to invest in China. The Chinese medical device market is the second largest in Asia, valued at $27.7 billion in 2014 and projected to grow at a CAGR of 10.6% to an estimated $50.8 billion in 2020.

These growth trends can be primarily attributed to the following causes -

  • Sedentary lifestyles leading to a high chronic disease burden.
  • The accessibility of healthcare professionals in the remote areas of the county.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in China, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: GlaxoSmithKline, Pfizer, AstraZeneca, Harbin Pharmaceutical Group and Tianjin Tasly Pharmaceutical; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Philips, Medtronic and F. Hoffman La Roche
  • Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving China's healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect China's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
  • Identify, understand, and capitalize on the opportunities and challenges in China's healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of Pharmaceutical and Medical Device Markets

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Exports and Imports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Overview of Top Five Disease Areas
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
    • 3.2.2. Overview of Top Five Segments
    • 3.2.3. Diagnostic Market
    • 3.2.4. Major Players
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Overview of the Healthcare System
  • 4.2. Reimbursement and Payer Landscape
    • 4.2.1. Reimbursement Process
    • 4.2.2. Overview of Insurance Providers
    • 4.2.3. Patient Share in Healthcare Spending
    • 4.2.4. Prescription Drug Price Trend
    • 4.2.5. Pricing Policies
  • 4.3. Regulatory Landscape
    • 4.3.1. Overview of Regulatory Agencies
    • 4.3.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.3.3. Market Authorization Procedure for Medical Devices
    • 4.3.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.3.5. Licensing Process for Pharmaceutical Exports and Imports
    • 4.3.6. Intellectual Property Rights
    • 4.3.7. Clinical Trial Regulations
    • 4.3.8. Pharmaceutical Advertising Regulations
    • 4.3.9. Pharmacy Regulations
    • 4.3.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of the Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. General Government Structural Balance
    • 5.3.9. General Government Gross Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy Rate
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Hospitals
    • 5.5.2. Healthcare Facilities
    • 5.5.3. Healthcare Parameters
    • 5.5.4. Environmental Health
    • 5.5.5. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Public and Private Sector Share
  • 5.7. Trade Associations
    • 5.7.1. China Chamber of Commerce for Import and Export of Medicines and Health Products
    • 5.7.2. China Healthcare Association
    • 5.7.3. Shanghai Medical Instrument Trade Association
    • 5.7.4. Chinese Hospital Association
    • 5.7.5. China Pharmaceutical Industry Association
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, China, Revenue ($bn), 2008-2014
  • Table 2: Pharmaceutical Market, China, Revenue Forecast ($bn), 2015-2020
  • Table 3: Pharmaceutical Market, China, Exports and Imports ($bn), 2008-2014
  • Table 4: GlaxoSmithKline, Global, Major Products, Revenue ($bn), 2014
  • Table 5: Late-stage Pipeline, GlaxoSmithKline, 2015
  • Table 6: Pharmaceutical Market, Pfizer, Global, Major Products, 2014
  • Table 7: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2015
  • Table 8: Major Products, AstraZeneca, Global, Revenue ($bn), 2014
  • Table 9: Late-stage Pipeline, AstraZeneca, 2015
  • Table 10: Major Products, Harbin Pharmaceuticals Group, 2015
  • Table 11: Major Products, Tasly, 2015
  • Table 12: Medical Device Market, China, Revenue ($bn), 2008-2014
  • Table 13: Medical Device Market, China, Revenue Forecast ($bn), 2014-2020
  • Table 14: Medical Device Market, China, Revenue by Segment, 2014
  • Table 15: Medical Device Market, China, Ophthalmic Devices Market, Revenue ($bn), 2008-2014
  • Table 16: Medical Device Market, China, Ophthalmic Devices Market, Market Share for Major Players, 2012
  • Table 17: Medical Device Market, China, Diagnostic Imaging Market, Revenue ($bn), 2008-2014
  • Table 18: Medical Device Market, China, Diagnostic Imaging Market, Market Share for Major Players, 2012
  • Table 19: Medical Device Market, China, In Vitro Diagnostic Market, Revenue ($bn), 2008-2014
  • Table 20: Medical Device Market, China, In Vitro Diagnostic Market, Market Share for Major Players, 2012
  • Table 21: Medical Device Market, China, Cardiovascular Device Market, Revenue ($bn), 2008-2014
  • Table 22: Medical Device Market, China, Cardiovascular Device Market, Market Share for Major Players, 2012
  • Table 23: Medical Device Market, China, Orthopedic Device Market, Revenue ($bn), 2008-2014
  • Table 24: Medical Device Market, China, Orthopedic Device Market, Market Share for Major Players, 2012
  • Table 25: Medical Device Market, China, Diagnostic Market, Revenue ($bn), 2008-2014
  • Table 26: Medical Device Market, China, Diagnostic Market, Revenue Forecast ($bn), 2015-2020
  • Table 27: Medical Device Market, China, Major Medical Device Companies, Revenue, 2012
  • Table 28: Medical Device Market, Major Products, Medtronic, 2014
  • Table 29: Healthcare Spending, China, Out-of-Pocket Expenditure (% of Total Healthcare Expenditure), 2008-2014
  • Table 30: Market Access, China, Healthcare Consumer Price Index, 2008-2014
  • Table 31: Economic Indicators, China, GDP per Capita ($), 2008-2014
  • Table 32: Economic Indicators, China, GDP per Capita Forecast ($), 2015-2020
  • Table 33: Economic Indicators, China, GDP Growth (%), 2008-2014
  • Table 34: Economic Indicators, China, GDP Annual Growth Forecast (%), 2015-2020
  • Table 35: Economic Indicators, China, Gross National Income per Capita ($), 2008-2014
  • Table 36: Economic Indicators, China, Average Consumer Price Index, 2008-2014
  • Table 37: Economic Indicators, China, Average Consumer Price Index Forecast, 2014-2020
  • Table 38: Economic Indicators, China, Average Consumer Price Change (%), 2008-2014
  • Table 39: Economic Indicators, China, Currency Exchange Rate (CNY/$), 2008-2014
  • Table 40: Economic Indicators, China, Foreign Direct Investment ($bn), 2008-2014
  • Table 41: Economic Indicators, China, Foreign Exchange Reserves ($tn), 2008-2014
  • Table 42: Economic Indicators, China, Trade Balance ($bn), 2008-2014
  • Table 43: Economic Indicators, China, Imports of Goods and Services ($tn), 2008-2014
  • Table 44: Economic Indicators, China, Exports of Goods and Services ($tn), 2008-2014
  • Table 45: Economic Indicators, China, Government Structural Balance ($bn), 2008-2014
  • Table 46: Economic Indicators, China, General Government Gross Debt ($tn), 2008-2014
  • Table 47: Economic Indicators, China, Major Industries, GDP by production ($tn), 2013
  • Table 48: Demographics, China, Population (billion), 2008-2014
  • Table 49: Demographics, China, Population Forecast (billion), 2015-2020
  • Table 50: Demographics, China, Population, Urban and Rural Population (%), 2008-2013
  • Table 51: Demographics, China Population Distribution by Age Group (%), 2008-2014
  • Table 52: Demographics, China, Population Distribution by Age Group Forecast (%), 2014-2020
  • Table 53: Demographics, China, Births (per 1,000 Population), 2008-2014
  • Table 54: Demographics, China, Mortality (per 1,000 Population), 2008-2014
  • Table 55: Demographics, China, Major Causes of Mortality (per 1,000 population), 2011
  • Table 56: Demographics, China, Children ≤5 Years, Mortality Rate (per 1,000 Live Births), 2008-2014
  • Table 57: Demographics, China, Immunization (%), 2008-2014
  • Table 58: Demographics, China, Major Causes of Male Mortality (%), 2011
  • Table 59: Demographics, China, Major Causes of Female Mortality (%), 2011
  • Table 60: Demographics, China, Gender Ratio (Males per 100 Females), 2008-2014
  • Table 61: Demographics, China, Life Expectancy (Years), 2008-2014
  • Table 62: Demographics, China, Student Enrollment by Level of Education (million), 2014
  • Table 63: Demographics, China, Unemployment Rate in Urban Areas (%), 2008-2014
  • Table 64: Demographics, China, Major Diseases, City Hospital In-Patients (%), 2011
  • Table 65: Demographics, China, Major Diseases, Share of County Hospital In-Patients (%), 2011
  • Table 66: Demographics, China, Major Diseases, DALY (per 100,000 Population), 2009
  • Table 67: Healthcare Infrastructure, China, Hospitals, 2008-2014
  • Table 68: Healthcare Infrastructure, China, Hospitals by Bed Size (%), 2011
  • Table 69: Healthcare Infrastructure, China, Hospitals Beds (million), 2008-2014
  • Table 70: Healthcare Infrastructure, China, Hospital Beds (per 1,000 Population), 2008-2014
  • Table 71: Healthcare Infrastructure, China, Doctors (per 1,000 Population), 2008-2014
  • Table 72: Healthcare Infrastructure, China, CO2 Emissions (Metric Tons per Capita), 2008-2014
  • Table 73: Healthcare Infrastructure, China, PM10 Emissions (µg/m3), 2008-2014
  • Table 74: Healthcare Infrastructure, China, Nurses (per 1,000 Population), 2008-2014
  • Table 75: Healthcare Expenditure, China, Healthcare Expenditure (% of GDP), 2008-2014
  • Table 76: Healthcare Expenditure, China, Public-Private Share of Healthcare Expenditure (%), 2008-2014
  • Table 77: Trade Fairs, China, Major Healthcare Trade Fairs, 2015

List of Figures

  • Figure 1: Pharmaceutical Market, China, Revenue ($bn), 2008-2014
  • Figure 2: Pharmaceutical Market, China, Revenue Forecast ($bn), 2015-2020
  • Figure 3: Pharmaceutical Market, China, Exports and Imports ($bn), 2008-2014
  • Figure 4: Pharmaceutical Distribution Channels, China, 2015
  • Figure 5: Medical Device Market, China, Revenue ($bn), 2008-2014
  • Figure 6: Medical Device Market, China, Revenue Forecast ($bn), 2014-2020
  • Figure 7: Medical Device Market, China, Revenue by Segment ($bn), 2014
  • Figure 8: Medical Device Market, China, Ophthalmic Devices Market, Revenue ($bn), 2008-2014
  • Figure 9: Medical Device Market, China, Ophthalmic Devices Market, Market Share for Major Players (%), 2012
  • Figure 10: Medical Device Market, China, Diagnostic Imaging Market, Revenue ($bn), 2008-2014
  • Figure 11: Medical Device Market, China, Diagnostic Imaging Market, Market Share for Major Players (%), 2012
  • Figure 12: Medical Device Market, China, In Vitro Diagnostic Market, Revenue ($bn), 2008-2014
  • Figure 13: Medical Device Market, China, In Vitro Diagnostic Market, Market Share for Major Players (%), 2012
  • Figure 14: Medical Device Market, China, Cardiovascular Device Market, Revenue ($bn), 2008-2014
  • Figure 15: Medical Device Market, China, Cardiovascular Device Market, Market Share for Major Players (%), 2012
  • Figure 16: Medical Device Market, China, Orthopedic Device Market, Revenue ($bn), 2008-2014
  • Figure 17: Medical Device Market, China, Orthopedic Device Market, Market Share for Major Players (%), 2012
  • Figure 18: Medical Device Market, China, Diagnostic Market, Revenue ($bn), 2008-2014
  • Figure 19: Medical Device Market, China, Diagnostic Market, Revenue Forecast ($bn), 2015-2020
  • Figure 20: Medical Device Market, China, Major Medical Device Companies, Revenue ($m), 2012
  • Figure 21: Healthcare Market, China, Drivers and Barriers, 2014
  • Figure 22: Healthcare System, China, Key Influences in Reimbursement Procedure, 2013
  • Figure 23: Healthcare Spending, China, Out-of-Pocket Expenditure (% of Total Healthcare Expenditure), 2008-2014
  • Figure 24: Market Access, China, Healthcare Price Index, 2008-2014
  • Figure 25: Market Access, SFDA Structure, 2013
  • Figure 26: Healthcare System, China, New Drug Approval Process, 2013
  • Figure 27: Healthcare System, China, New Medical Device Approval Process, 2013
  • Figure 28: Economic Indicators, China, GDP per Capita ($), 2008-2014
  • Figure 29: Economic Indicators, China, GDP per Capita Forecast ($), 2015-2020
  • Figure 30: Economic Indicators, China, GDP Growth (%), 2008-2014
  • Figure 31: Economic Indicators, China, GDP Growth Forecast (%), 2015-2020
  • Figure 32: Economic Indicators, China Gross National Income per Capita ($), 2008-2014
  • Figure 33: Economic Indicators, China, Average Consumer Price Index, 2008-2014
  • Figure 34: Economic Indicators, China, Average Consumer Price Index Forecast, 2014-2020
  • Figure 35: Economic Indicators, China, Average Consumer Price Change (%), 2008-2014
  • Figure 36: Economic Indicators, China, Currency Exchange Rate (CNY/$), 2008-2014
  • Figure 37: Economic Indicators, China, Foreign Direct Investment ($bn), 2008-2014
  • Figure 38: Economic Indicators, China, Foreign Exchange Reserves ($tn), 2008-2014
  • Figure 39: Economic Indicators, China, Trade Balance ($bn), 2008-2014
  • Figure 40: Economic Indicators, China, Imports ($tn), 2008-2014
  • Figure 41: Economic Indicators, China, Exports ($tn), 2008-2014
  • Figure 42: Economic Indicators, China, Government Structural Balance ($bn), 2008-2014
  • Figure 43: Economic Indicators, China, General Government Gross Debt ($tn), 2008-2014
  • Figure 44: Economic Indicators, China, Major Industries, GDP by Production ($tn), 2013
  • Figure 45: Demographics, China, Population (billion), 2008-2014
  • Figure 46: Demographics, China, Population Forecast (bn), 2015-2020
  • Figure 47: Demographics, China, Population, Urban and Rural Population (%), 2008-2014
  • Figure 48: Demographics, China, Population Distribution by Age Group (%), 2008-2014
  • Figure 49: Demographics, China, Population Distribution by Age Group Forecast (%), 2015-2020
  • Figure 50: Demographics, China, Birth Rate (per 1,000 Population), 2008-2014
  • Figure 51: Demographics, China, Mortality (per 1,000 Population), 2008-2014
  • Figure 52: Demographics, China, Major Causes of Mortality (per 1,000 population), 2011
  • Figure 53: Demographics, China, Children ≤5 Years, Mortality Rate (per 1,000 Live Births), 2008-2014
  • Figure 54: Demographics, China, Immunization (%), 2008-2014
  • Figure 55: Demographics, China, Main Causes of Male Mortality (%), 2011
  • Figure 56: Demographics, China, Major Causes of Female Mortality (%), 2011
  • Figure 57: Demographics, China, Gender Ratio (Males per 100 Females), 2008-2014
  • Figure 58: Demographics, China, Life Expectancy (Years), 2008-2014
  • Figure 59: Demographics, China, Student Enrollment by Level of Education (million), 2014
  • Figure 60: Demographics, China, Unemployment Rate in Urban Areas (%), 2008-2014
  • Figure 61: Demographics, China, Major Diseases, City Hospital In-Patients (%), 2011
  • Figure 62: Demographics, China, Major Diseases, Share of County Hospital In-Patients (%), 2011
  • Figure 63: Demographics, China, Major Diseases, DALY (per 100,000 Population), 2009
  • Figure 64: Healthcare Infrastructure, China, Hospitals, 2008-2014
  • Figure 65: Healthcare Infrastructure, China, Hospitals by Bed Number (%), 2011
  • Figure 66: Healthcare Infrastructure, China, Hospitals Beds (million), 2008-2014
  • Figure 67: Healthcare Infrastructure, China, Hospital Beds (per 1,000 Population), 2008-2014
  • Figure 68: Healthcare Infrastructure, China, Doctors (per 1,000 Population), 2008-2014
  • Figure 69: Healthcare Infrastructure, China, CO2 Emissions (Metric Tons per Capita), 2008-2014
  • Figure 70: Healthcare Infrastructure, China, PM10 Emissions (µg/m3), 2008-2014
  • Figure 71: Healthcare Infrastructure, China, Nurses (per 1,000 Population), 2008-2014
  • Figure 72: Healthcare Expenditure, China, Healthcare Expenditure (% of GDP), 2008-2014
  • Figure 73: Healthcare Expenditure, China, Public-Private Share of Healthcare Expenditure (%), 2008-2014
  • Figure 74: Healthcare Market, China, Opportunities and Challenges, 2014
Back to Top